Roland F. Baumgartner

Solna, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

PCSK6 ablation in blood circulating cells increases atherosclerotic burden, but improves plaque stability by activating Th17-smooth muscle cell modulatory axis.

PCSK6 ablation in blood circulating cells increases atherosclerotic burden, but improves plaque stability by activating Th17-smooth muscle cell modulatory axis.

Journal: Vascular pharmacology

Published: December 28, 2024

The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells.

The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells.

Journal: ACS synthetic biology

Published: February 07, 2023

Expanding the CRISPR toolbox for Chinese hamster ovary cells with comprehensive tools for Mad7 genome editing.

Expanding the CRISPR toolbox for Chinese hamster ovary cells with comprehensive tools for Mad7 genome editing.

Journal: Biotechnology and bioengineering

Published: October 05, 2022

CRISPR-Cas12a-integrated transgenes in genomic safe harbors retain high expression in human hematopoietic iPSC-derived lineages and primary cells.

CRISPR-Cas12a-integrated transgenes in genomic safe harbors retain high expression in human hematopoietic iPSC-derived lineages and primary cells.

Journal: iScience

Published: September 19, 2022

Pyruvate dehydrogenase kinase regulates vascular inflammation in atherosclerosis and increases cardiovascular risk.

Pyruvate dehydrogenase kinase regulates vascular inflammation in atherosclerosis and increases cardiovascular risk.

Journal: Cardiovascular research

Published: September 09, 2022

Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice.

Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice.

Journal: Frontiers in cardiovascular medicine

Published: December 07, 2021

CRISPR-Cas12a nucleases function with structurally engineered crRNAs: SynThetic trAcrRNA.

CRISPR-Cas12a nucleases function with structurally engineered crRNAs: SynThetic trAcrRNA.

Journal: Scientific reports

Published: October 21, 2021

Disruption of GPR35 Signaling in Bone Marrow-Derived Cells Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice.

Disruption of GPR35 Signaling in Bone Marrow-Derived Cells Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice.

Journal: Metabolites

Published: June 01, 2021

The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection.

The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection.

Journal: The Journal of clinical investigation

Published: August 03, 2020

Evidence that a deviation in the kynurenine pathway aggravates atherosclerotic disease in humans.

Evidence that a deviation in the kynurenine pathway aggravates atherosclerotic disease in humans.

Journal: Journal of internal medicine

Published: February 21, 2020

Immunomodulatory effects of interferon-γ on human fetal cardiac mesenchymal stromal cells.

Immunomodulatory effects of interferon-γ on human fetal cardiac mesenchymal stromal cells.

Journal: Stem cell research & therapy

Published: August 15, 2019

Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability.

Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability.

Journal: Circulation

Published: March 22, 2019

Showing 1-12 of 31

Last Updated: 09/26/2026